Auna S.A (AUNA) to offer additional 10.000% senior notes

Auna S.A. (NYSE: AUNA), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced that it intends to offer additional 10.000% senior secured notes (the “Additional Notes”) in a private offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended, and outside the United States to non-U.S. persons in accordance with Regulation S under the Securities Act. The Additional Notes will be an issuance of Auna's existing 10.000% senior secured notes due 2029 and will be issued as additional notes under the indenture dated as of December 18, 2023 pursuant to which Auna previously issued US$ 310,837,161 aggregate principal amount of 10.000% senior secured notes due 2029 (the “Initial Notes”). The Additional Notes will be of the same class and series as, and otherwise identical to, the Initial Notes other than with respect to the date of issuance, issue price and first interest payment date. The Additional Notes are expected to be fully and unconditionally guaranteed on a senior secured basis by certain of the Company's subsidiaries.

The timing of pricing and terms of the Additional Notes are subject to market conditions and other factors. The proceeds from the Additional Notes offering will be used by the Company to partially prepay indebtedness under the credit agreement, dated as of November 10, 2023, and to pay related interests, fees and expenses.

This press release does not constitute an offer to sell or a solicitation of an offer to buy these securities, nor will there be any sale of these securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state or jurisdiction. The Additional Notes and related guarantees have not been registered under the Securities Act, or any applicable state securities laws, and will be offered only to qualified institutional buyers pursuant to Rule 144A promulgated under the Securities Act and outside the United States to non-U.S. persons in accordance with Regulation S under the Securities Act. Unless so registered, the Additional Notes and related guarantees may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act and any applicable state securities laws.

About Auna

Auna is a leading healthcare platform in Latin America with operations in Mexico, Peru and Colombia, prioritizing prevention and concentrating on high-complexity diseases that contribute the most to healthcare expenditures. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest modern healthcare platforms that consists of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio of oncological plans and selected general healthcare plans. As of December 31, 2024, Auna’s network included 31 healthcare network facilities, consisting of hospitals, outpatient, prevention and wellness facilities with a total of 2,323 beds, and 1.4 million healthcare plans.

You May Also Be Interested In

• Nuvectis Pharma (NVCT) files $200M mixed shelf
• RBC Capital Starts Reformation Inc (REF) at Outperform
• Sigma Lithium resumes full operations after signing TAC agreement